# Advisory Committees; Conversion of Ad Hoc Advisory Committee to Standing Advisory Committee
> **Food and Drug Administration** · Final rule. · Published 1996-07-12 · Effective 1996-07-12 · 61 FR 36624
## Document
- **Document number:** 96-17686
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 61 FR 36624
- **CFR reference:** 21 CFR 14
- **Publication date:** 1996-07-12
- **Effective date:** 1996-07-12
## Abstract

The Food and Drug Administration (FDA) is amending the standing advisory committees' regulations to add the name and function of the Transmissible Spongiform Encephalopathies Advisory Committee (formerly Ad Hoc Advisory Committee on Creutzfeldt-Jakob Disease). Appearing elsewhere in this issue of the Federal Register is a notice announcing the renewal of this advisory committee. A notice requesting nominations for membership on this committee will publish at a later date. This action is being taken to incorporate this committee into the agency's list of standing advisory committees because it will no longer be serving in an ad hoc capacity.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1996/07/12/96-17686/advisory-committees-conversion-of-ad-hoc-advisory-committee-to-standing-advisory-committee)
---
*AI Analytics · CC0 1.0*